Gemmer Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-54
Closed – – 776
2022
Q1
$0 Sell
54
-112
-67% -$2.36K ﹤0.01% 1286
2021
Q4
$6K Hold
166
– – ﹤0.01% 928
2021
Q3
$8K Hold
166
– – ﹤0.01% 785
2021
Q2
$7K Hold
166
– – ﹤0.01% 962
2021
Q1
$8K Hold
166
– – ﹤0.01% 860
2020
Q4
$9K Hold
166
– – ﹤0.01% 738
2020
Q3
$6K Hold
166
– – ﹤0.01% 805
2020
Q2
$5K Hold
166
– – ﹤0.01% 854
2020
Q1
$5K Buy
166
+79
+91% +$2.37K ﹤0.01% 756
2019
Q4
$3K Sell
87
-53
-38% -$1.26K ﹤0.01% 1152
2019
Q3
$3K Buy
140
+97
+226% +$2.27K ﹤0.01% 1163
2019
Q2
$1K Buy
+43
New +$944 ﹤0.01% 1324

Other funds holding NEO

Gemmer Asset Management's NEO Position: Q2 2022 in Review

Gemmer Asset Management sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 54 shares.

Gemmer Asset Management first reported a position in NEO in Q2 2019 and held it in 12 quarters. The position peaked at $9K in Q4 2020. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Gemmer Asset Management reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Gemmer Asset Management sold 54 NeoGenomics shares in Q2 2022.
  • Gemmer Asset Management first reported a position in NeoGenomics in Q2 2019 and held it in 12 quarters.
  • Gemmer Asset Management's NeoGenomics position peaked at $9K in Q4 2020.
  • 239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.